DAFTAR PUSTAKA
1. El-Zimaity HMT. Recent advances in the histopathology of gastritis. Current Diagnostic Pathology. 2007;13:340-8.
2. Rugge M, Genta RM. Staging and grading of chronic gastritis. Human pathology. 2005;36:228-33.
3. Fox JG, Megraud F. Helicobacter. In: Murray PR, editor. Manual of clinical microbiology. 9th ed. Pensylvania: Elsevier Mosby; 2007. hlm.947-62.
4. Cesar ACG, Cury PM, Payao SLM. Comparison of histological and molecular diagnosis of Helicobacter pylori in benign lesions and gastric adenocarcinoma. Braz J Microbiol. 2005;36(1):261-6.
5. Banerjee A, Mukhopadhyay AK, Paul S, Bhattacharyya A and Swarnakar S. Unveiling the Intricacies of Helicobacter pylori-induced Gastric Inflammation: T Helper cells and Matrix Metalloproteinases at a Crossroad. In: Mozsik G, editor. Current Topics in Gastritis. Croatia: InTech Publishers; 2013. Chapter 7.
6. Rehnberg-Laiho L, Rautelin H, Koskela P, Sarna S, Pukkala E, Aromaa A, et al. Decreasing prevalence of helicobacter antibodies in Finland, with
reference to the decreasing incidence of gastric cancer. Epidemiol Infect. 2001;126:37-42.
7. Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, et al. Genetic differences in interleukin-1 betapolymorphisms among four Asian populations: an analysis of the Asian paradox between H. pylori infection and gastric cancer incidence. J Exp Clin Cancer Res. 2003; 22: 47-55.
8. Xuan J, Deguchi R, Yanagi H, Ozawa H, Urano T, Ogawa Y, et al. Relationship between gastric mucosal IL-8 levels and histological gastritis in patients with Helicobacter pylori infection. Tokai J Exp Clin Med. 2005;30(2):83-8.
with functional dyspepsia, with and without Helicobacter pylori infection. FEMS Immunology and Medical Microbiology.2005;44:233–8.
10. Koskensalo S, Mrena J, Wiksten JP, Nordling S, Kokkola A, Hagstrom J, et al, 2010. MMP-7 overexpression is an independent prognostic marker in gastric cancer. Tumor Biol. (2010) 31: 149-155
11. Caruso R, Fina D, Peluso I, Tosti C, Blanco GDV, et al. IL-21Is Highly Produced in Helicobacter pylori- Infected Gastritis Mucosa and Promotes Gelatinases Synthesis J Immunol 2007;178: 5957-5965
12. Zhang Qiong-Wen, Liu Lei, Chen Ru, Wei Yu-Quan , Li Ping, Shi Hua-Shan ,
Zhao Yu-Wei.: Matrix Metalloproteinase-9 as a Prognostic Factor in Gastric Cancer: A Meta-Analysis. Asian Pacific Journal of Prevention,vol 13,2012. P 2903-2908
13.Rhee Jae Won, Lee Keun-Wook, Kim Dongbum , Lee Younghee, Jeon Ok-Hee,
Kwon Hyung-Joo , Kim Doo-Sik : 94 NF-κB-dependent Regulation of Matrix Metalloproteinase-9 Gene Expression by Lipopolysaccharide in a Macrophage Cell Line RAW 264.7. Journal of Biochemistry and Molecular Biology, Vol. 40, No. 1, January 2007, pp. 88-94
14.Toljamo K. Gastric erosions – clinical significance and pathology. A long-term follow-up study. University of Oulu, Finland:Acta Univ Oul; 2012.hlm 1-80.
15. Hirlan, Gastritis dalam Buku Ajar Ilmu Penyakit Dalam Edisi 5, Internal Publishing : 2009 ; 509-512
16. S Iiyas. Repository.usu.ac.id.2013
17. Szoke D. Genetic factors related to the histological and macroscopic lesions of the stomach. [disertasi]. Budapest: Semmelweis University; 2009. Hlm 7-61
19. Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, Russo VM, et al. Gastritis: the histology report. Digestive and Liver Disease. 2011; 43S:S373– 84.
20. Adibi P. Gastritis. [Diunduh 19 Mei 2014]. Tersedia dari: 21. Zakaria Z. The role of interleukin-10 in Helicobacter pylori infection. Master
[Tesis]. Nottingham,UK: University of Nottingham; 2010.hlm. 55.
22. Adam B, et al. Cellular immune activation and clinical manifestation of funcional dyspepsia. Z Gastroenterol 2008;46-v26
23. Elseweidy MM. Helicobacter pylori ifection and its relevant to chronic gastritis. INTECH.2013.http://dx.doi.org/105772/46056
24. Conteduca vincenza, domenico sansonno, gianfranco lauletta, sabino russi, giuseppe ingravallo and franco dammacco. H. pylori infection and gastric cancer: State of the art. international journal of oncology. 2013.42: 5-18. 25. D W, Chey, C B, Wong. American college of gastroenterology guidline on
the management of H.pylori infetion. Am J Gastroenterol 2007;102:1808-1825.
26. Simadibrata M. Dyspepsia and Gastroesophageal Reflux Disease (GERD): Is There Any Correlation? Acta Med Indones. 2009; 41(4): 222-7.
27. Silva MIG, de Sousa FCF. Gastric ulcer etiology. In: Chai J, editor. Peptic Ulcer Disease. Shanghai: Intech; 2011. hlm. 3-28.
28.Syam AF, Sadikin M, Wanandi SI, Rani AA. Molecular mechanism on healing process of peptic ulcer. Acta Med Indones. 2009;41(2):95-8.
29.Brzozowski T. Experimental production of peptic ulcer, gastric damage and cancer models and their use in pathophysiological studies and pharmacological treatment–polish achievement. J Phyl Pharmacol. 2003;54:99-126
31. Wallace JB. Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn’t the Stomach Digest Itself? American Physiological Society. Physiol Rev 88: 1547-1565, 2008Zhao X, Wang Q, Qian Y, Song JL,. Ilex kudingcha C.J. Tseng (Kudingcha) prevents HCl/ethanol induced gastric injury in Sprague Dawley rats. Molecular Medicine Reports. 2013;7:1613-6.
32. Mueller, A., et al., Profiling of microdissected gastric epithelial cells reveals a cell type—specific response to Helicobacter pylori infection.
Gastroenterology, 2004. 127(5): p. 1446-1462.
33. Fischer, W., et al., Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and
induction of interleukin‐8. Molecular Microbiology, 2003. 47(6): p. 1759-1759.
34. Sundrud, M.S., et al., Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects
on IL-2 secretion. Proceedings of the National Academy of Sciences of the
United States of America, 2004. 101(20): p. 7727-7732.
35.Pelicic V, Reyrat JM, Sartori L, Pagliaccia C, Rappuoli R, Telford JL, et al. Helicobacter pylori VacA cytotoxin associated with the bacteria increases epithelial permeability independently of its vacuolating activity. Microbiology. 1999;145(8): 2043-50.
36.Lu, H., et al., Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology, 2005. 128(4): p. 833-848.
37.Yamaoka, Y., et al., Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut, 2006. 55(6): p. 775-781.
38.Rad, R., et al., The Helicobacter pylori blood group antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune
response. The Journal of Immunology, 2002. 168(6): p. 3033-3041.
39.Montecucco, C. and M. de Bernard, Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein
40.Chung HW, Lim JB, 2014. Role of the tumor microenvironment in the pathogenesis of gastric carcinoma. World J Gastroenterol 2014; 20(7): 1667-1680
41. Tarnawski AS, Chai J, Jones MK. Esophageal and Gastrointestinal Microcirculation: Essential for Mucosal Protection, a Target for Injury, and a Critical Component of Injury and Ulcer Healing. In: Ishii H, Suematsu M, Tanishita K, editor. Organ microcirculation: a gateway to diagnostic and therapeutic intervention. Tokyo: Springer; 2005. Hlm 49-61.
42. Zhao X, Wang Q, Qian Y, Song JL,. Ilex kudingcha C.J. Tseng (Kudingcha) prevents HCl/ethanol induced gastric injury in Sprague Dawley rats. Molecular Medicine Reports. 2013;7:1613-6.
43. Tanigawa T, Watanabe T, Higuchi K, Machida H, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, et al: Lansoprazole, a Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis Factoralpha and Interleukin-1beta Induced by Lipopolysaccharide and Helicobacter Pylori Bacterial Components in Human Monocytic Cells via Inhibition of Activation of Nuclear Factor-kappaB and Extracellular Signal-Regulated Kinase. J Clin Biochem Nutr. 2009, 45(1):86–92.
44.Lee HJ, Han YM, Kim EH, Kim YJ, Hahm KB. A possible involvement of Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the proton pump inhibitor pantoprazole against indomethacin-induced gastric damage in rats. BMC Gastroenterology. 2012;12:143Bradley JR. TNF-mediated inflammatory disease. J Pathol. 2008; 214:149-60.
45. Rakananurak N, Sallapant S, Prueksapanich P, Somanawat K, Klaikaew N, Rerknimitr R, et al. Aloe vera Improved Gastric Injury on Nonsteroidal Anti-Inflammatory Drugs-Induced Gastropathy in Rats. Thai J Gastroenterol. 2013; 14(2):87-92.
47. Naito Y, Yoshikawa T, Yagi N, Matsuyama K, Yoshida N, Seto K, et al. Effects of polaprezinc on lipid peroxidation, neutrophil accumulation, and TNF- expression in rats with aspirin-induced gastric mucosal injury. Dig Dis Sci. 2001;46:845–51.
48. Jainu M, Devi CSS. Gastroprotective action of Cissus quadrangularis extract against NSAID induced gastric ulcer: role of proinflammatory cytokines and oxidative damage. Chem Biol Interact. 2006;161:262–70
49. Konturek PC, Duda A, Brzozowski T, Konturek SJ, Kwiecien S, Drozdowicz D, et al. Activation of genes for superoxide dismutase, interleukin-1beta, tumor necrosis factor-alpha, and intercellular adhesion molecule-1 during healing of ischemia-reperfusion-induced gastric injury. Scand J Gastroenterol. 2000;35(5):452-63
50. Fox JG, Wang TC. Inflammation, atrophy and gastric cancer. The Journal of Clinical
51. Israel DA, Peek RM. Review article: Pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol Ther. 2001;15:1271-90. 52. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. British
Med Bull. 1998;54:139-50
53. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology. 2002;123(1):92-105
54. Holck S, Norgaard A, Bennedsen M, Permin H, Norn S, Andersen LP, et al. Gastric mucosal cytokine responses in Helicobacter pylori-infected patients with gastritis and peptic ulcers. Association with inflammatory parameters and bacteria load. FEMS Immunology and Medical Microbiology. 2003;36:175-80.
56.Al-Ashy R, Chakroun I, El-Sabban ME, Homaidan FR. The role of NF-kappaB in mediating the anti-inflammatory effects of IL-10 in intestinal epithelial cells. Cytokine. 2006; 36:1-8.
57. Kriskova S, Zitka O, Masarik M et al. Clinical Importance of matrix metalloproteinases. Bratisl Lek Listy 2011;112(8):435-440
58.Amalinei C, Caruntu ID, Giusca SE et all. Matrix metalloproteinases involvement in pathologic conditions. Romanian Journal of Morphology and Embryology 2010, 51(2):215–228.
59. Verma RP
biological functions and (Q)SARs
60. Angulo JC
of bladder cancer using real-time RT-PCR for gelatinases (MMP-2, MMP-9) and TIMP-2 in peripheral bl
61.Sampieri CL, Cordoba KL, Troche JMR, 2013.Matrix metalloproteinases and their tissue inhibitors in gastric cancer as molecular markers. Review Article.Journal of Cancer Research and Therapeutics, 2013.Volume 9-Issue 3. 62. Decocks J, Paridaens R, Ye S. Genetic polymorphisms of matrix
metalloproteinases in lung, breast and colorectal cancer. Clinical Genetics, An International Journal of Genetics, Molecular and Personalized Medicine.
63. Charoenrat PO, Rhys-Evans PH, Eccles SA. Expression of Matrix Metalloproteinases and Their Inhibitors Correlates With Invasion and Metastasis in Squamous Cell Carcinoma of the Head and Neck. Arch Otolaryngol Head Neck Surg. 2001;127(7):813-820
65. Musumba C, Pritchard DM, Primohamed M : Cellular and molecular mechanisms of NSAID-induces peptic ulcers. Alimentary Pharmacology and Therapeutics 30,2009. Blackwell Publishing . p517-531
66.Detrick, B., C. Nagineni, and J. Hooks, Cytokines: Regulators of Immune Responses and Key Therapeutic Targets In: MRGOGaAD Donnenberg.
Human Immunology, CRC Press, Taylor & Francis Group, 2008: p. 495-516 67.Baratawidjaja KG. Imunologi Dasar: Sitokin. Jakarta: Balai Penerbit FK-UI;
2004. hlm. 128-31
68.Bradley JR. TNF-mediated inflammatory disease. J Pathol. 2008; 214:149-60. 69.Genersch Elke, Hayeß Katrin, Neuenfeld Yvette and Haller Hermann.
Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and-independent pathways. Journal of Cell Science 113, 4319-4330 (2000) 4319 Printed in Great Britain © The Company of Biologists Limited 2000
JCS1673
70.Amieva MR, Salama NR, Tompikns LS and Falkov S. Helicobacter pylori Enter and Survive within Multivesiculer Vacuoles of Ephithelial Cells. Cellular Mikrobiology. 2002; 4(10):677
71.Visse R and Nagase H. Matrix Metalloproteinase and Tissue Inhibitors of Metalloproteinase; Stucture, Function, and Biochemistry. Circulation Research. 2003;8:827-839
72.Gibbs D.F. Warner R.L. , Weiss S. J., Johnson K.J., Varani J. 1999. Characterization of Matrix Metalloproteinases Products by Rat Alveolar
macrophages . Am.J. Respir. Cell Moll . Biol. 20(6), 1136-1144.
73.Garg B, Sandhu V, Sood N, Sood A, Malhotra V. Histopathological analysis of chronic gastritis and correlation of pathological features with each other and with endoscopic findings. Pol J Pathol. 2012;3:172-8.
75. determinants of Helicobacter pylori sero-positivity in the Australian adult community. J Gastroenterology Hepatology.2011 ;Aug;26(8):1283-9
76.Betty. Infeksi Helicobacter pylori pada lesi gastritis yang didiagnosa dengan Pewarnaan Histokimia Giemsa dan Imunohistokimia Helicobacter pylori di Laboratorium Patologi Anatomi Fakultas Kedokteran USU Medan. 2012.
77.Parameswaran I, Hubungan peningkatan kadar leukosit dan neutropil dengan infeksi H.pylori di RSU Permata Bunda Medan.2014.
78.Zho Y, et al. Risk factors and prevalence of H.Pylori infection in persistent high incidence area of gastric carcinoma in Yangzhong city.2014.
79.Naja F,et al. Helicobacter pylori in Ontario : prevalence and rsik factors.Jurnal canadian of gastroenterologi. 2007:21(8):501-506
80.Abidiev S, Ahn KS, Khadjibaev A, Malikov Y, Bahramov S, Rakhimov B, et al. Helicobacter pylori infection and cytokine gene polymorphisms in Uzbeks. Nagoya J Med Sci, 2010;72:167-72
81.Salama NR, Hartung ML, Müller Anne. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nature Reveiws Microbiol. 2013;11:385-99
82.Hoyer KK, Dooms H, Barron L, Abbas AK. Interleukin-2 in the development and control of inflammatory disease. Immun Reviews. 2008; 226:19-28
83.Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterol, 1998;114(3):482-92.
85.Adam B, et al. Cellular immune activation and clinical manifestation of funcional dyspepsia. Z Gastroenterol 2008;46-v26
86.Joshi A, Gupta SD, Ahuja V, Sharma MP. Symptom score does not correlate with gastritis grade and Helicobacter pylori infection in non ulcer dyspepsia. Trop Gastroenterol 2001;22:194-6.
